Table 3.
Multivariate regression analysis for follow-up outcomes.
| Outcomes |
Crude Analysis |
P value | Hazard Ratio (95 %CI) | P value $ | |
|---|---|---|---|---|---|
| Standard dose | Escalated dose | ||||
| In-hospital mortality, n/N(%) Δ | 64/173 (37.0) | 65/171 (38.0) | 0.85^^ | 1.08 (0.76, 1.53) | 0.67 |
| 30-day mortality, n/N(%) Δ | 48/173 (27.7) | 54/172 (31.4) | 0.46^^ | 1.17 (0.79, 1.73) | 0.43 |
| Beta- coefficient (95 %CI) | P-value $* | ||||
| ICU Length of Stay(Days), Median (Q1, Q3) & | 9.0 (5.0,15.0) | 8.0 (5.0,13.0) | 0.39^ | −0.12 (-0.31, 0.07) | 0.23 |
| Hospital Length of Stay(Days), Median (Q1, Q3) & | 17.0 (11.0,24.0) | 14.0 (10.0,24.0) | 0.22^ | −0.11 (-0.27, 0.06) | 0.20 |
| MV duration (Days), Median (Q1, Q3) & | 6.0 (1.0, 13.0) | 3.0 (0.0, 10.0) | 0.29^ | -0.17 (-0.58, 0.24) | 0.41 |
Δ The Denominator is the total number of patients
& Denominator is the number of patients who survived.
^ Wilcoxon rank-sum test is used to calculate the P-value.
^^ Chi-square test is used to calculate the P-value.
$* Propensity score is used to calculate Beta- coefficient (estimate) and p-value.
$ Propensity score is used to calculate hazard ratio and p-value.